A Phase 1 Single and Multiple Ascending Dose Study of LTG-001 Administered Orally in Healthy Participants

NCT06049095 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

204

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LTG-001
DRUG: Placebo

Sponsor

Latigo Biotherapeutics